Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
about
Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancercuratedOvarianData: clinically annotated data for the ovarian cancer transcriptomeInhibition of glutathione peroxidase mediates the collateral sensitivity of multidrug-resistant cells to tioproninApoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor.Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics.The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene.The clinical relevance of cancer cell lines.Novel risk models for early detection and screening of ovarian cancer.Recently identified drug resistance biomarkers in ovarian cancer.Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
P2860
Q27694658-86ACC47B-1978-483C-AFB2-562F73000A0BQ30611147-00005F04-AE8D-4F17-A8D7-B65E1E50DD77Q33985320-57D95297-73B7-4B69-90E6-C0CAF9A3A6E2Q34335802-C1CB3EF2-BC3C-4E08-A099-2179DDE8DB95Q34491120-3EF9B7AA-B910-4AF8-9DA8-C4F63A2A23DDQ35212386-3413EE15-67C8-4E6A-B003-E878D3B9C248Q36087199-BDD32F5B-2ECA-4299-90EA-004BC65670BCQ36104522-0ADBED0A-5B09-4A21-A476-D19DFA40680BQ36199823-1B11A7CA-47CD-425E-98F5-BC1BAE8CFC6AQ36812960-5DF8DDCF-2EB4-4639-AAD2-A77F0384F7D1Q36953572-10C11A21-56A1-4E74-A306-B45D6516D093Q37702354-080F98B4-FD37-41CF-8BB4-BFC2A7250600Q38741073-550D41DC-F2F8-49C6-8190-998E56807566Q39405849-A5D7406E-E190-4448-86BC-6E37F6C54444Q47344966-78877F41-2B05-48F6-954A-245836328A27
P2860
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@ast
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@en
type
label
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@ast
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@en
prefLabel
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@ast
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@en
P2093
P2860
P1476
Multidrug resistance-linked ge ...... imary ovarian serous carcinoma
@en
P2093
Anil K Sood
Anna Maria Calcagno
Aparna A Kamat
Ben Davidson
Bo R Rueda
Jean-Pierre Gillet
Mari Bunkholt Elstrand
Michael M Gottesman
Michael V Seiden
Ram Ganapathi
P2860
P304
P356
10.1158/1078-0432.CCR-12-0056
P407
P577
2012-04-05T00:00:00Z